ABVC BioPharma, Inc. (ABVC) Financials

$1.37

$0.03 (-2.14%)
Last update: 04:00 PM EST
Day's range
$1.33
Day's range
$1.4
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20MEarning201820182019201920202020202120212022202220232023202420240%0%-20000%-20000%-40000%-40000%-60000%-60000%-80000%-80000%-100000%-100000%Profit Margin
Profit Margin
Revenue
Earnings

ABVC Income statement / Annual

Last year (2024), ABVC BioPharma, Inc.'s total revenue was $508,826.00, an increase of 233.81% from the previous year. In 2024, ABVC BioPharma, Inc.'s net income was -$4.90 M. See ABVC BioPharma, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 09/30/2016 09/30/2015
Operating Revenue $508,826.00 $152,430.00 $969,783.00 $355,797.00 $483,045.00 $701,719.00 $6,956.00 $3,196.00 $32.00 $3,360.00
Cost of Revenue $763.00 $302,037.00 $286,415.00 $5,086.00 $18,716.00 $20,137.00 $185,280.00 $2,249.00 $32.00 $521.00
Gross Profit $508,063.00 -$149,607.00 $683,368.00 $350,711.00 $464,329.00 $681,582.00 -$178,324.00 $947.00 $0.00 $2,839.00
Gross Profit Ratio 1 -0.98 0.7 0.99 0.96 0.97 -25.64 0.3 0 0.84
Research and Development Expenses $179,272.00 $1.06 M $2.69 M $1.00 M $549,658.00 $1.05 M $669,668.00 $256,682.00 $10.00 M $0.00
General & Administrative Expenses $5.03 M $7.00 M $13.10 M $11.05 M $8.42 M $3.09 M $723,948.00 $1.74 M $4.50 M $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $695,148.00 $1.74 M $4.50 M $0.00
Selling, General & Administrative Expenses $5.03 M $7.00 M $13.10 M $11.05 M $8.42 M $3.09 M $723,948.00 $1.74 M $4.50 M $35,120.00
Other Expenses $0.00 $0.00 $83,000.00 -$360,898.00 $199,641.00 $116,846.00 $0.00 $63,388.00 $0.00 $35,120.00
Operating Expenses $5.01 M $8.07 M $15.80 M $11.70 M $8.97 M $4.14 M $1.39 M $1.99 M $4.50 M $35,120.00
Cost And Expenses $5.21 M $8.37 M $16.08 M $11.70 M $8.99 M $4.16 M $1.39 M $1.99 M $4.50 M $35,641.00
Interest Income $87,358.00 $185,481.00 $187,817.00 $43,196.00 $71,045.00 $23,344.00 $93.00 $7,207.00 $361.00 $0.00
Interest Expense $825,899.00 $2.49 M $293,968.00 $227,210.00 $405,032.00 $482,014.00 $155,930.00 $222,060.00 $10,170.00 $0.00
Depreciation & Amortization $200,921.00 $28,531.00 $23,799.00 $11,993.00 $37,142.00 $55,086.00 $43,610.00 $43,996.00 $11.00 M $1.89 M
EBITDA -$4.34 M -$8.22 M -$15.20 M -$10.97 M -$10.37 M -$3.47 M -$2.74 M -$4.00 M $561.00 -$32,281.00
EBITDA Ratio -8.53 -53.9 -15.67 -30.84 -21.47 -4.95 -394.04 -1250.42 17.53 -9.61
Operating Income Ratio -9.25 -53.9 -15.59 -31.89 -17.61 -4.93 -200.35 -623.17 -140540.47 -9.61
Total Other Income/Expenses Net -$664,334.00 -$2.44 M -$400,184.00 $495,141.00 -$2.31 M -$551,503.00 -$1.31 M -$3.03 M -$9,668.00 $0.00
Income Before Tax -$5.37 M -$10.65 M -$15.51 M -$11.21 M -$10.81 M -$4.01 M -$4.10 M -$7.03 M -$4.51 M -$32,281.00
Income Before Tax Ratio -10.55 -69.9 -16 -31.51 -22.39 -5.71 -589.34 -2199.72 -140842.59 -9.61
Income Tax Expense -$110,539.00 $256,006.00 $797,778.00 $825,024.00 -$220,352.00 -$77,041.00 $1,850.00 -$360,395.00 $836.00 -$1.89 M
Net Income -$4.90 M -$10.52 M -$16.31 M -$12.04 M -$10.59 M -$3.93 M -$4.10 M -$5.05 M -$4.51 M -$32,281.00
Net Income Ratio -9.64 -68.99 -16.82 -33.83 -21.93 -5.61 -589.61 -1579.56 -140868.72 -9.61
EPS -0.43 -2.43 -5.15 -4.8 -5.37 -2.25 -3.53 -4.3 -4.18 -0.37
EPS Diluted -0.43 -2.43 -5.15 -4.8 -5.37 -2.25 -3.45 -4.3 -4.18 -0.37
Weighted Average Shares Out $12.41 M $4.34 M $3.17 M $2.51 M $1.97 M $1.75 M $1.16 M $170,669.00 $1.08 M $87,266.00
Weighted Average Shares Out Diluted $12.41 M $4.34 M $3.17 M $2.51 M $1.97 M $1.75 M $1.19 M $170,669.00 $1.08 M $87,266.00
Link